Article
SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
23 Nov 2021
Abstract excerpt
The morbidity and mortality of autoimmune diseases (Ads) have been increasing worldwide, and the identification of novel therapeutic strategies for prevention and treatment is urgently needed. Sirtuin 1 (SIRT1), a member of the class III family of nicotinamide adenine dinucleotide (NAD + )-dependent histone deacetylases, has been reported to participate in the progression of several diseases. SIRT1 also regulates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
